Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Central Compounding Center South is a U.S. compounding-only pharmacy in Durham, North Carolina that prepares customized prescription medications for human and veterinary patients. The business focuses on personalized formulations made in collaboration with prescribers, with services spanning hormone replacement therapy, sterile compounds such as ophthalmic preparations and methyl-B12, erectile dysfunction medications, nutritional supplementation, and veterinary medicines. The company presents itself as operating state-of-the-art compounding facilities and notes PCAB accreditation through ACHC, along with participation in professional compounding organizations. It is a healthcare services business rather than a drug-development biotech, and its activities are centered on commercial pharmacy compounding rather than a proprietary clinical pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Central Compounding Center South.